
COVID-19
The Texas A&M Engineering Experiment Station National Center for Therapeutics Manufacturing meets the need for workers.
The Texas A&M Bush School of Government & Public Service will host a panel of experts for a virtual discussion Thursday, April 22.
Texas A&M Lab Identifies New COVID-19 Variant; Genome Suggests Potential Resistance To Antibodies
Apr 19, 2021 • 4 min. readA single case led to only mild symptoms. The variant is named BV-1 for its Brazos Valley origin.
A new model developed at Texas A&M has proved successful in predicting COVID-19 infection rates two to three weeks in advance.
It only took eight days for a technology team at Texas A&M Health to develop the Brazos County COVID-19 Vaccination Hub online registration system.
Reflecting On COVID-19 And A Growing Public Health Threat
Apr 14, 2021 • 5 min. readTexas A&M Hagler Fellow Peter Hotez discussed the state of the pandemic and the growing anti-science movement during a recent talk hosted by the School of Public Health.
Restrictions lifted on travel within Texas.
The collaborative study shows enzyme inhibitor K777 is effective in combatting SARS-CoV-2.
The messenger molecule that’s been in every living cell for billions of years is the key ingredient in some COVID-19 vaccines, a Texas A&M expert explains.
Texas A&M To Participate In National Study On COVID-19 Transmission After Vaccination
Apr 2, 2021 • 5 min. readStudent volunteers will participate in a clinical trial to determine if vaccinated people can still spread the virus.